Call For Papers
The International Journal of Glaucoma is actively seeking original research that improves prevention, diagnosis, and treatment of glaucoma and related optic neuropathies. We prioritize clinically meaningful work that supports evidence based care and real world impact.
Published articles are immediately accessible to clinicians, researchers, and policy makers worldwide, helping evidence move faster into practice and improving outcomes for patients. We value submissions with robust methods and clear clinical implications.
We welcome submissions from multidisciplinary teams, including ophthalmologists, vision scientists, biomedical engineers, and public health researchers working to reduce the global burden of glaucoma.
Advance glaucoma care through open access
The International Journal of Glaucoma welcomes high quality submissions that deepen clinical understanding, improve diagnostic precision, and advance therapies that preserve vision. We seek impactful research that can be translated into practice and policy across diverse patient populations.
Our editorial board includes glaucoma specialists, vision scientists, and biostatisticians committed to fair, timely review. Published articles are immediately available worldwide under open access, expanding the reach of your findings.
Priority focus areas
- Early detection strategies and screening programs
- Optic nerve imaging, OCT, and visual field analytics
- Intraocular pressure management and medication adherence
- Minimally invasive glaucoma surgery and surgical outcomes
- Neuroprotection, genetics, and disease mechanisms
- Patient quality of life, health economics, and access to care
Accepted article types
We consider original research, systematic reviews, meta analyses, clinical trials, short communications, case series, and evidence based practice updates. Submissions should align with glaucoma and ocular hypertension research or closely related fields within vision science.
Why publish with IJG
IJG combines specialist editorial oversight with open access visibility. Authors benefit from structured peer review, clear communication, and global reach across clinicians, researchers, and policy makers.
- Open access distribution that removes subscription barriers
- Expert reviewers with glaucoma and vision science expertise
- Structured metadata to improve discoverability and citations
Review process and timelines
All submissions receive editorial screening followed by independent peer review. Decision letters include clear guidance for revisions so that authors can respond efficiently.
Submission preparation checklist
- Structured abstract with key findings and clinical relevance
- Clear description of study design and statistical methods
- Ethics approval and consent statements where applicable
- Data availability statement and repository links if available
Ethics and transparency
We encourage transparent reporting of methods, conflicts of interest, and funding sources. These elements improve trust and help clinicians interpret results accurately.
Early career researchers are welcome to submit well designed studies. Clear methodology and responsible reporting are valued more than institution size or funding level.
We encourage multi center and international collaborations that reflect diverse patient populations and practice settings.
Well designed studies with negative or null results are welcome when they advance clinical understanding.
Submission options
Submit through Manuscriptzone for full tracking or use the Simple Manuscript Submission form for quick upload. Both routes connect to the same editorial workflow.
- Manuscriptzone submission: https://oap.manuscriptzone.net/
- Simple Manuscript Submission: https://openaccesspub.org/manuscript-submission-form
Featured Research Themes
Early Detection
Risk stratification, community screening models, and AI assisted optic nerve evaluation that improve early diagnosis before irreversible loss.
Pressure Control
Medical, laser, and surgical strategies that optimize intraocular pressure while balancing adherence and quality of life.
Surgical Innovation
Trabeculectomy outcomes, tube shunts, and minimally invasive techniques that improve safety and durability.
Imaging and Diagnostics
OCT, OCT angiography, perimetry analytics, and multimodal imaging that clarify structural and functional change.
Neuroprotection
Mechanistic insights, neurotrophic pathways, and emerging therapies that address pressure independent progression.
Population Outcomes
Health services research, disparities, and cost effectiveness studies that guide public health policy and access.
Pediatric Glaucoma
Congenital and juvenile glaucoma research, surgical outcomes, and long term visual development studies.
AI and Digital Health
Automated screening, tele ophthalmology, and decision support tools that expand care access.
Real World Evidence
Registry studies, adherence research, and treatment outcomes that inform everyday glaucoma management.
Special Issue Opportunities
Special issues are welcomed when they highlight emerging themes or consensus priorities. If you have a proposal or want to serve as a guest editor, we encourage an early conversation so that timelines and outreach can be aligned.
Authors can indicate a special issue in the cover letter so that submissions are routed to the correct editorial pathway.
If your work is time sensitive, note this in the cover letter and the editorial team will advise on feasibility.
A concise cover letter that explains novelty and clinical relevance helps editors assign the right reviewers quickly.
If you have suggested reviewers, include them in the submission notes.
Submissions are accepted year round.
Concise briefs are welcome.
Need Guidance From Our Editorial Team?
We are happy to clarify policies, submission routes, and editorial requirements.
[email protected]Submit Your Glaucoma Research
Choose a submission route and share your findings with the global vision science community.
